A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infectionRichard Elion, Javier Szwarcberg, José Ramón Arribas et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2013Cited by 41
A Randomized Study of Tenofovir Disoproxil Fumarate in Treatment-experienced HIV-1 Infected AdolescentsMarinella Della Negra, Martin S. Rhee, Jeffrey Enejosa et al.|The Pediatric Infectious Disease Journal|2012Cited by 24
A Randomized, Open-Label Study of the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate in HIV-1–infected Children With Virologic SuppressionXavier Sáez‐Llorens, Martin S. Rhee, Andrew Cheng et al.|The Pediatric Infectious Disease Journal|2014Cited by 19